Study to Investigate the Effects of Talampanel on the Heart Rhythm
- Study Title
- A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
- Teva Identifier
- TAL-TQT-101 | R09-0539
- ClinicalTrials.gov Identifier
- NCT00964730
- Study Status
- Completed
- Trial Condition(s)
- Healthy
- Interventions
- Drug: Talampanel | Drug: Moxifloxacin | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- 10/01/2009 - 02/01/2010
- Phase
- Phase 1
